Seminars in Oncology

Papers
(The H4-Index of Seminars in Oncology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Clinical efficacy and security analysis of DEB-TACE combined with trans arterial infusion of carrelizumab in the therapy of advanced liver cancer56
Breaking barriers: Deciphering the mechanisms of Olaparib resistance in prostate cancer53
Hepatitis B Virus Reactivation in Cancer Patients Receiving Chemotherapy—A Systematic Review and Meta-Analysis31
Airway disorders associated with immune checkpoint inhibitor therapy: Two case reports and a systematic review30
Integrated analysis of scRNA-seq and bulk RNA-seq data identifies BHLHE40 as a key gene in pancreatic cancer progression and gemcitabine resistance24
Overexpression of CAD in stomach adenocarcinoma tissues and its clinical significance20
Unlocking the therapeutic potential of polyphenols: Promising advances and future directions in pancreatic cancer treatment20
Explainable machine learning and feature interpretation to predict survival outcomes in the treatment of lung cancer18
Deciphering the US Regulatory Framework: Comparison Between Oncology Biosimilars and Reference Biologics18
Table of Contents18
Pretreatment eosinophilia as a biomarker for adverse outcomes in non-small cell lung cancer patients receiving immune checkpoint inhibitors: A systematic review and meta-analysis18
Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations17
Psoas muscle depletion correlates with poor prognosis and compromised immunity in resectable gastric cancer: A multicenter study17
Editorial Board16
0.078146934509277